The CSF amyloid beta 1–42(Aβ 1–42) level was 116 pg/mL and that of phosphorylated tau(P-tau) was 41 pg/mL, consistent with the diagnosis of Alzheimer’s disease [27]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.